Risk factor
Very poor trading liquidity
Profitability factor
Very low or no dividends
About
Optomed Oyj, a medical technology company, manufactures and sells handheld fundus cameras and screening software in Finland, China, and internationally. The company operates through two segments, Devices and Software segments. The company develops, manufactures, and sells fundus camera products, which are used by ophthalmologists, pediatricians, endocrinologists, neurologists, and primary care professionals. It offers camera products...
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers.
Target Price
The average target price of OPTOMED.HE is 4.8 and suggests 28% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to i
Buy
Sell